BioLife Solutions

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$-3,424
$30,571
$28,328
$31,727
Gross Profit
8,271
21,806
14,893
11,647
EBITDA
6,747
853
-4,375
-7,605
EBIT
5,043
-1,464
-6,737
-9,883
Net Income
12,459
-1,703
-20,719
-10,221
Net Change In Cash
-3,424
30,571
28,328
31,727
Free Cash Flow
583
3,688
5,464
-4,831
Cash
95,386
23,977
22,014
29,725
Basic Shares
46,067
46,175
46,004
45,432

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$82,254
$143,271
$161,759
$119,156
Gross Profit
57,752
46,752
53,822
37,748
EBITDA
1,532
-45,238
-23,190
-17,784
EBIT
-7,129
-57,533
-43,148
-32,702
Net Income
-20,184
-66,427
-139,805
-8,383
Net Change In Cash
82,254
143,271
161,759
119,156
Free Cash Flow
5,204
-18,879
-18,874
-13,221
Cash
95,386
35,407
19,442
69,870
Basic Shares
46,067
43,719
42,481
38,503

Earnings Calls

Quarter EPS
2024-12-31
-$0.01
2024-09-30
-$0.01
2024-06-30
-$0.50
2024-03-31
-$0.23